Your browser doesn't support javascript.
loading
Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.
Dai, Chengyi; Luo, Wu; Chen, Yanghao; Shen, Siyuan; Wang, Zhe; Chen, Ruijie; Wang, Jun; Chattipakorn, Nipon; Huang, Weijian; Liang, Guang.
Afiliación
  • Dai C; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
  • Luo W; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
  • Chen Y; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
  • Shen S; Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.
  • Wang Z; Department of Pharmacy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  • Chen R; Department of Pharmacy, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
  • Wang J; Department of Cardiology, Wenzhou Central Hospital and Affiliated Dingli Clinical Institute, Wenzhou Medical University, Wenzhou 325035, Zhejiang, China.
  • Chattipakorn N; Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
  • Huang W; Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: weijianhuang69@126.com.
  • Liang G; Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Department of Cardiology and Medical Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; School of Pharmaceutic
Phytomedicine ; 103: 154238, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35696800
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Angiotensina II / Quinasas Quinasa Quinasa PAM / Insuficiencia Cardíaca Idioma: En Revista: Phytomedicine Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Angiotensina II / Quinasas Quinasa Quinasa PAM / Insuficiencia Cardíaca Idioma: En Revista: Phytomedicine Año: 2022 Tipo del documento: Article País de afiliación: China